Cultura

DuPont expected to win proxy fight against Trian's Peltz

WILMINGTON, Delaware (Reuters) - DuPont apparently prevailed in a proxy fight against activist investor Nelson Peltz for board seats, his fund said on Wednesday.

"It appears that the Trian nominees were not elected to the DuPont Board," Peltz's Trian Fund Management said in a statement.

Trian had been seeking four seats on DuPont's board.

Peltz told the shareholder meeting on Wednesday that the vote would be close.

The vote ends a high-stakes corporate drama engulfing the 213-year-old chemical company that revved up in January when Trian announced its dissident board slate.

DuPont shares fell 6 percent in premarket trading.

(Reporting by Tom Hals in Wilmington and Swetha Gopinath in Bengaluru; Writing by Lewis Krauskopf in New York; Editing by Lisa Von Ahn)

WhatsAppFacebookFacebookTwitterTwitterLinkedinLinkedinBeloudBeloudBluesky